| 1. |
2023
Tangeretin and 4'-demethyltangeretin prevent damage to mouse hepatocytes from oxidative stress by activating the Nrf2-related antioxidant pathway via an epigenetic mechanism
. Chem Biol Interact
.2023
|
|
| 2. |
2023
Wu TY,Tien N,Lin CL,Cheah YC,Hsu CY,Tsai FJ, Fang YJ, Lim YP.
Influence of antipsychotic medications on hyperlipidemia risk in patients with schizophrenia: evidence from a population-based cohort study and in vitro hepatic lipid homeostasis gene expression
. Front Med (Lausanne)
.2023
|
|
| 3. |
2023
Hsieh HH,Wu TY,Chen CH,Kuo YH, Hour MJ.
Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort study
. Ther Adv Drug Saf
.2023
|
|
| 4. |
2023
Tien N,Wu TY,Lin CL,Chu FY,Wang CCN,Hsu CY, Tsai FJ, Fang YJ, Lim YP.
Association of epilepsy, anti-epileptic drugs (AEDs), and type 2 diabetes mellitus (T2DM): a population-based cohort retrospective study, impact of AEDs on T2DM-related molecular pathway, and via peroxisome proliferator-activated receptor γ transactivation.
. Front Endocrinol
.2023
|
|
| 5. |
2023
Hsieh HH,Wu TY,Chen CH,Kuo YH,Hour MJ.
Survival Outcomes of Calcium Channel Blocker Therapy in Patients With Non-Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Inhibitors: A Retrospective Study
. Integr Cancer Ther
.2023
|
|
| 6. |
2023
Hsieh HH,Wu TY,Chen CH,Kuo YH,Hour MJ.
Clinical impact of tetracyclines and/or proton pump inhibitors on the efficacy of epidermal growth factor receptor inhibitors in non-small cell lung cancer: a retrospective cohort study
. BMC Cancer
.2023
|
|
| 7. |
2022
Tien N,Wu TY,Lin CL,Wu CJ,Hsu CY,Fang YJ, Lim YP.
Impact of Inflammatory Bowel Disease (IBD) and IBD Medications on Risk of Hyperlipidemia and in vitro Hepatic Lipogenic-Related Gene Expression: A Population-Based Cohort Study
. Front Med
.2022
|
|
| 8. |
2022
Chang CC,Hsu HJ,Wu TY,Liou JW.
Computer-aided discovery, design, and investigation of COVID-19 therapeutics.
. Tzu Chi Med J
.2022
|
|
| 9. |
2022
Kapelemera AM,Uang YS,Wang LH,Wu TY,Lee FY,Tai L, Wang CC, Lee CJ.
Pharmacokinetic Herb-Drug Interactions of Xiang-Sha-Liu-Jun-Zi-Tang and Paclitaxel in Male Sprague Dawley Rats and Its Influence on Enzyme Kinetics in Human Liver Microsomes
. Front Pharmacol
.2022
|
|
| 10. |
2021
Hsieh HH,Wu TY,Chen CH,Hour MJ.
Cost-effectiveness and clinical outcomes of intermittent/continuous proton pump inhibitors infusion in high bleeding risk of ulcers: A retrospective observational cohort study.
. Medicine
.2021
|
|
| 11. |
2021
Tien N,Wu TY,Lai JN,Lin CL,Hsiao YC,Khaw JY, Lim YP.
Influences of antidepressant medications on the risk of developing hyperlipidemia in patients with depression by a population-based cohort study and on in vitro hepatic lipogenic-related gene expression
. J Affect Disord
.2021
|
|
| 12. |
2021
Fang YJ,Wu TY,Lai JN,Lin CL,Tien N,Lim YP.
Association between Depression, Antidepression Medications, and the Risk of Developing Type 2 Diabetes Mellitus: A Nationwide Population-Based Retrospective Cohort Study in Taiwan
. Biomed Res Int
.2021
|
|
| 13. |
2021
Su YS,Kuo MZ,Kuo YT,Huang SW, Lee CJ,Su ZY, Ni YH, Li DK, Wu TY.
Diterpenoid anthraquinones as chemopreventive agents altered microRNA and transcriptome expressions in cancer cells
. Biomed Pharmacother
.2021
|
|
| 14. |
2020
Fang YJ,Wu TY,Lin CL,Su CY,Li JR,Chung YL, Tien N, Lim YP.
Effects of Urate-Lowering Therapy on Risk of Hyperlipidemia in Gout by a Population-Based Cohort Study and on In Vitro Hepatic Lipogenesis-Related Gene Expression
. Mediators Inflamm
.2020
|
|
| 15. |
2020
Wu TY,Wang CH,Tien N,Lin CL,Chu FY,Chang HY, Lim YP.
A Population-Based Cohort Study on the Association of Hyperthyroidism With the Risk of Hyperlipidemia and the Effects of Anti-thyroid Drugs on Hepatic Gene Expression.
. Front Med
.2020
|
|
| 16. |
2020
Chen CH,Hsieh HH,Wu TY.
Real-world prevalence of hepatitis B virus reactivation in cancer patients in Taiwan.
. J Oncol Pharm Pract
.2020
|
|
| 17. |
2020
Wu TY,Lin JN,Luo ZY,Hsu CJ,Wang JS,Wu HP.
2,3,4',5-Tetrahydroxystilbene-2-O-β-D-Glucoside (THSG) Activates the Nrf2 Antioxidant Pathway and Attenuates Oxidative Stress-Induced Cell Death in Mouse Cochlear UB/OC-2 Cells.
. Biomolecules
.2020
|
|